Lumigan — Class III drug recall D-0667-2017
Terminated recall by Allergan Sales, LLC, reported 2017-04-19, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0667-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Allergan Sales, LLC, Waco, TX, United States |
| Recall initiated | 2017-03-16 |
| Classified | 2017-04-12 |
| Reported by FDA | 2017-04-19 |
| Terminated | 2019-05-01 |
| Distributed | Nationwide (US) |
| Quantity | 56,878 bottles |
| Reason classes | specification failure |
| NDC | 00023-3205, 00023-3205-02, 00023-3205-03, 00023-3205-05, 00023-3205-08 |
| Lot numbers | 92577 |
| Expiration dates | 2018-06-20 |
Product
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0667-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.